世界中西医结合杂志
世界中西醫結閤雜誌
세계중서의결합잡지
WORLD JOURNAL OF TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
8期
876-877,900
,共3页
豨莶通栓丸%脑梗死%血脂%纤维蛋白原%美国国立卫生院卒中量表(NIHSS)
豨薟通栓汍%腦梗死%血脂%纖維蛋白原%美國國立衛生院卒中量錶(NIHSS)
희렴통전환%뇌경사%혈지%섬유단백원%미국국립위생원졸중량표(NIHSS)
Xixian Tongshuan Wan%Cerebral Infarction%Blood Lipid%Fibrinogen%National Institutes of Health Stroke Scale(NIHSS)
目的：观察莶通栓丸对脑梗死患者的临床疗效及其血脂、纤维蛋白原（FIB）水平的影响。方法将100例患脑梗死（病程为1个月内）同时伴有高血脂、高纤维蛋白原血症的患者分为治疗组和对照组。对照组40例，常规治疗。治疗组60例，在常规治疗的基础上加用莶通栓丸每次1丸；3次·d-1。两组均4周为1个疗程。比较治疗前后两组患者血脂、FIB水平的变化及以美国国立卫生院卒中量表（NIHSS）进行神经系统功能缺损评分的变化。结果治疗后两组血清总胆固醇（TC）、甘油三酯（TG）、FIB水平、NIHSS评分均有下降，治疗组下降明显，两组比较差异有统计学意义（P＜0．01）。两组均未见不良反应发生。结论莶通栓丸治疗脑梗死疗效确切、安全，且能显著降低脑梗死患者的血脂、FIB水平及NIHSS评分。
目的：觀察薟通栓汍對腦梗死患者的臨床療效及其血脂、纖維蛋白原（FIB）水平的影響。方法將100例患腦梗死（病程為1箇月內）同時伴有高血脂、高纖維蛋白原血癥的患者分為治療組和對照組。對照組40例，常規治療。治療組60例，在常規治療的基礎上加用薟通栓汍每次1汍；3次·d-1。兩組均4週為1箇療程。比較治療前後兩組患者血脂、FIB水平的變化及以美國國立衛生院卒中量錶（NIHSS）進行神經繫統功能缺損評分的變化。結果治療後兩組血清總膽固醇（TC）、甘油三酯（TG）、FIB水平、NIHSS評分均有下降，治療組下降明顯，兩組比較差異有統計學意義（P＜0．01）。兩組均未見不良反應髮生。結論薟通栓汍治療腦梗死療效確切、安全，且能顯著降低腦梗死患者的血脂、FIB水平及NIHSS評分。
목적：관찰렴통전환대뇌경사환자적림상료효급기혈지、섬유단백원（FIB）수평적영향。방법장100례환뇌경사（병정위1개월내）동시반유고혈지、고섬유단백원혈증적환자분위치료조화대조조。대조조40례，상규치료。치료조60례，재상규치료적기출상가용렴통전환매차1환；3차·d-1。량조균4주위1개료정。비교치료전후량조환자혈지、FIB수평적변화급이미국국립위생원졸중량표（NIHSS）진행신경계통공능결손평분적변화。결과치료후량조혈청총담고순（TC）、감유삼지（TG）、FIB수평、NIHSS평분균유하강，치료조하강명현，량조비교차이유통계학의의（P＜0．01）。량조균미견불량반응발생。결론렴통전환치료뇌경사료효학절、안전，차능현저강저뇌경사환자적혈지、FIB수평급NIHSS평분。
Objective To observe the impacts of xixian tongshuan wan on the clinical efficacy and the levels of blood lipid and fibrinogen(FIB)in the patients of cerebral infarction.Methods One hundred patients of cerebral infarction(duration of sickness:<1 month),combined with hyperlipidemia and hyperfi-brinogenemia were divided into a treatment group and a control group.Forty cases in the control group were treated with conventional therapy.Sixty cases in the treatment group were treated with xixian tongshuan wan on the basis of the conventional therapy,1 pill each time,three times a day.The treatment of 4 weeks made one session in the two groups.The levels of blood lipid and FIB were compared before and after treatment,as well as the changes in nerve function defect score evaluated by the National Institutes of Health Stroke Scale (NIHSS).Results The results of serum total cholesterol,triglyceride and NIHSS were reduced after treat-ment in the two groups,and the reduce was more apparent in the treatment group,indicating the significant difference as compared with the control group(P<0.01 ).The adverse reactions were not discovered in the two groups.Conclusion Xixian tongshuan wan achieves the definite and safe efficacy on cerebral infarction and significantly reduces the levels of blood lipid,FIB and NIHSS in the patients.
